Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout
Works of Munehiro Ito being referenced
Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non–Small Cell Lung Cancer
2017
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Munehiro Ito | 312 | 476 | 10 | 79 | 13 | 533 | |
| Balazs Medgyasszay | 417 | 566 | 1 | 88 | 7 | 612 | |
| Maria Cristina Bruna | 254 | 234 | 1 | 97 | 13 | 471 | |
| Shawn Kothari | 172 | 398 | 10 | 93 | 12 | 514 | |
| Kyoji Tsurumi | 226 | 481 | 6 | 102 | 10 | 518 | |
| Junliang Cai | 387 | 441 | 60 | 12 | 516 | ||
| Keisuke Terayama | 224 | 480 | 6 | 102 | 10 | 518 | |
| Yutaka Domeki | 223 | 480 | 6 | 102 | 10 | 516 | |
| Anika E. Adeni | 245 | 545 | 2 | 155 | 19 | 615 | |
| Tomoiki Aiba | 228 | 483 | 6 | 105 | 18 | 528 | |
| Kuninobu Kanai | 308 | 423 | 3 | 95 | 24 | 605 |
All Works
Login with ORCID to disown or claim papers
Loading papers...